A Study to Investigate the Association of Real-world Sensor-derived Biometric Data With Clinical Parameters and Patient-reported Outcomes for Monitoring Disease Activity in Patients With COPD
Condition: Pulmonary Disease, Chronic Obstructive Intervention: Device: Vivalink wearable device Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials
Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination with KEYTRUDA (pembrolizumab), Met Primary Efficacy Endpoint in Phase 2b KEYNOTE-942 Trial
mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a statistically significant and clinically meaningful reduction in the risk of disease recurrence or death compared to KEYTRUDA monotherapy in stage III/IV melanoma patients with high risk... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 13, 2022 Category: Pharmaceuticals Source Type: clinical trials
Dragonfly Therapeutics Announces First Patient Dosed in Clinical Trial Evaluating Solid Tumor Targeting TriNKET Conducted by Merck
WALTHAM, Mass., Nov. 1, 2022. Dragonfly Therapeutics, Inc. ( " Dragonfly " ), today announced that the first patient has been dosed in a clinical trial being conducted by Merck, known as MSD outside the United States and Canada, to evaluate a solid... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 1, 2022 Category: Pharmaceuticals Source Type: clinical trials
